๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prognostic tissue markers in melanoma

โœ Scribed by David A Moore; J Howard Pringle; Gerald S Saldanha

Book ID
108781113
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
94 KB
Volume
60
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Molecular prognostic markers in intermed
Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma
โœ Tina J. Hieken; Salve G. Ronan; Miguel Farolan; Anne L. Shilkaitis; Tapas K. Das ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 233 KB ๐Ÿ‘ 2 views

## Background: The limitations of morphologic criteria alone in determining the prognosis for a patient with a particular intermediate-thickness primary melanoma have prompted efforts to identify other markers. ## Methods: In this study, the authors analyzed expression of p53, beta1 integrin, and

Osteopontin as a molecular prognostic ma
Osteopontin as a molecular prognostic marker for melanoma
โœ Javier Rangel; Mehdi Nosrati; Sima Torabian; Ladan Shaikh; Stanley P. L. Leong; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 292 KB

## Abstract ## BACKGROUND. Osteopontin has been suggested as a marker of disease progression in patients with melanoma because of its overexpression in recent microarray analyses. However, its prognostic role in melanoma has not been fully defined. ## METHODS. Osteopontin expression status was e